My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.150 -0.030 (-1.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

$100 Invested In Cassava Sciences 20 Years Ago Would Be Worth This Much Today ↗

November 16, 2022

Via Benzinga

Why Is Cassava Sciences (SAVA) Stock Up Today? ↗

November 14, 2022

Today's big move in Cassava Sciences and SAVA stock has many investors watching this company's trials closer than ever.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

Is the Stock Market Open on Election Day 2022? ↗

November 07, 2022

Investors are wondering if the stock market is open on Election Day this year as they seek out extra time to head to the polls!

Via InvestorPlace

Cassava Sciences Has a Big Warning for SAVA Stock Short Sellers ↗

November 07, 2022

SAVA stock is in the green after reporting earnings. The company also filed a lawsuit against short sellers, alleging misleading statements.

Via InvestorPlace

Cassava Sciences: Q3 Earnings Insights ↗

November 07, 2022

Cassava Sciences (NASDAQ:SAVA) reported its Q3 earnings results on Monday, November 7, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

What the Latest Controversy Really Means for SAVA Stock ↗

November 07, 2022

SAVA stock continues to be dogged by controversy, but the risk/reward proposition for this biotech largely remains the same.

Via InvestorPlace

Why Is Cassava Sciences (SAVA) Stock Down 10% Today? ↗

November 02, 2022

SAVA stock is in the red after a piece from Probes Reporter accused Cassava of being involved with two undisclosed SEC investigations.

Via InvestorPlace

A New Study Makes Cassava Sciences Stock an Interesting Buy ↗

October 31, 2022

With the biotech firm moving forward with an open-label study of its Alzheimer's treatment simufilam, SAVA stock is one to watch.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

October 24, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

October 20, 2022

As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

SAVA Stock Alert: Cassava Sciences Extends Trial ↗

October 13, 2022

SAVA stock is in focus after Cassava announced that it would begin an open-label study of its investigational Alzheimer's drug, simufilam.

Via InvestorPlace

Don’t Let Misconduct Allegations Cloud Your Perception of SAVA Stock ↗

October 11, 2022

It's easy to get mired in the controversy surrounding Cassava Sciences, but distracted SAVA stock traders might miss an opportunity.

Via InvestorPlace

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

2 Signals to Watch Before Buying SAVA Stock ↗

October 05, 2022

SAVA stock got ahead of itself in September, but if it continues to pull back, a solid entry point could emerge for this risky biotech play.

Via InvestorPlace

EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank? ↗

October 04, 2022

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

$100 Invested In Cassava Sciences 15 Years Ago Would Be Worth This Much Today ↗

October 03, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 15 years by 3.29% on an annualized basis producing an average annual return of 9.08%. Currently, Cassava Sciences has a market...

Via Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today ↗

September 30, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 20 years by 4.23% on an annualized basis producing an average annual return of 12.02%. Currently, Cassava Sciences has a market...

Via Benzinga

How High Can SAVA Stock Go Once the Controversy Clears? ↗

September 30, 2022

If a reproduced SEC letter concerning Cassava Sciences' clearance is legit, SAVA stock could head much higher.

Via InvestorPlace

'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company ↗

September 30, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock.

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

Why Is Acumen (ABOS) Stock Up 95% Today? ↗

September 28, 2022

Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company.

Via InvestorPlace

What Is Going on With Silo Pharma (SILO) Stock Today? ↗

September 28, 2022

Silo Pharma (SILO) stock is in the news Wednesday as investors react to the company uplisting shares to the Nasdaq Exchange.

Via InvestorPlace

Why Is Taiwan Semiconductor (TSM) Stock Down Today? ↗

September 28, 2022

Taiwan Semiconductor (TSM) stock isn't doing so hot Wednesday on reports that Apple (AAPL) is decreasing production for the iPhone 14.

Via InvestorPlace

Why Is Cassava Sciences (SAVA) Stock Heating Up Today? ↗

September 28, 2022

SAVA stock rose 5% on the success of Biogen in slowing cognitive decline from Alzheimer's, but its Simufilam has a different target.

Via InvestorPlace

US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗

September 28, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.

Via Benzinga

Why Cassava Sciences Shares Are Soaring Higher ↗

September 28, 2022

Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.

Via Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

September 28, 2022

U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

Caution! It’s Not Safe to Jump on the SAVA Stock Hype Train. ↗

September 27, 2022

Rumors and speculation surrounding Cassava Sciences incited a buying frenzy in SAVA stock, but this isn't the time to jump on the hype train.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.